Please provide your email address to receive an email when new articles are posted on . Most women with PCOS treated with tirzepatide experienced 5% or more, 10% or more and 15% or more weight loss.

If you’ve hit your 40s or 50s and noticed that your usual “eat less, move more” plan suddenly…stopped working, you’re not alone. Hormonal shifts, changes in muscle mass, sleep disruption, stress – ...

ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...

It’s an unfair fact of life that women care most about their weight, and also face the greatest challenges to keeping it down. These challenges emerge early on and usually worsen with age. There’s ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

Don’t want to do intense cardio to lose weight? You don’t have to.

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Please provide your email address to receive an email when new articles are posted on . Use of hormonal birth control was linked with less weight loss after 12 months in a behavioral weight loss ...